Article Sidebar

PDF
Date Published: 17/03/2023
Abstract Views: 229
Views PDF: 147
DOI: https://doi.org/10.51298/vmj.v524i1A.4661
Issue
Vol. 524 No. 1A (2023)
Section
Các bài báo
How to Cite
Trần , C. V. ., & Phạm , T. M. P. . (2023). SUPERFICIAL FUNGAL INFECTION ON SKIN LESION OF PATIENT WITH PSORIASIS AT NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY. Vietnam Medical Journal, 524(1A). https://doi.org/10.51298/vmj.v524i1A.4661

SUPERFICIAL FUNGAL INFECTION ON SKIN LESION OF PATIENT WITH PSORIASIS AT NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY

Cẩm Vân Trần 1,, Thị Minh Phương Phạm 1
1 National Hospital of Dermatology and Venereology

Main Article Content

Abstract

Objectives: To investigate the prevalence of superficial fungal infection on skin lesion of patient with psoriasis at National hospital of Dermatology and Venereology from January 2016 to December 2019. Population and methods: Cross-sectional description. The patient was diagnosed with psoriasis and have test of direct examination for fungi. Results: The prevalence of superficial fungal infection was 9.4%, there was no difference in age and gender. Dermatophytes were common with 42%, followed by Malassezia 34.9% and Candida with the lowest rate of 23.1%. The prevalence of Malassezia in psoriasis vulgaris was higher than other with p<0.05. The prevalence of Dermatophytes in pustular psoriasis was higher than other with p<0.05. Candida infection was found in all clinical form. Conclusion: Superficial fungal infections on skin lesions of patient with psoriasis were common, maily caused by Dermatophytes, Malassezia spp. and Candida spp.

Article Details

Keywords

superficial fungal infection, psoriasis

References

1. Boehncke W.H., Schön M.P. (2015). Psoriasis. Lancet, 386(9997), 983-994.
2. Lowes M.A., Russell C.B., Martin D.A. et al (2013). The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol, 34(4), 174-181.
3. Kamiya K., Kishimoto M., Sugai J. et al (2019). Risk factors for the development of psoriasis. International Journal of Molecular Sciences, 20(18), 4347.
4. Chadeganipour M., Shadzi S., Mohammadi R. (2021). Fungal infections among psoriatic patients: etiologic agents, comorbidities, and vulnerable population. Autoimmune Diseases, 2021,
5. Pietrzak A., Grywalska E., Socha M. et al (2018). Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Mediators Inflamm, 2018, 9602362.
6. Sparber F., Ruchti F., LeibundGut-Landmann S. (2020). Host immunity to Malassezia in health and disease. Frontiers in cellular and infection microbiology, 10, 198.
7. Sepahi S., Riahi-Zanjani B., Ghorani-Azam A. (2016). The role of Candida albicans in the pathogenesis of psoriasis vulgaris: a systematic literature review. Reviews in Clinical Medicine, 3(3), 122-127.
8. Papini M., Natalini Y. (2018). Candida infections in psoriatic patients on anti-IL17 therapy: a case series. Journal of Dermatological Treatment, 29(sup2), 3-4.
9. Rudramurthy S.M., Honnavar P., Chakrabarti A. et al (2014). Association of Malassezia species with psoriatic lesions. Mycoses, 57(8), 483-488.
10. Kyriakou A., Zagalioti S.-C., Trakatelli M.-G. et al (2022). Fungal Infections and Nail Psoriasis: An Update. Journal of Fungi, 8(2), 154.